Poster Abstract Session:
253. Vaccines: PCV
Saturday, October 10, 2015: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:


Tracks: Pediatric ID, Adult ID

Distance to health services modifies the effect of an 11-valent pneumococcal vaccine (PCV) on pneumonia risk among children less than 2 years of age in Bohol, Philippines
Elisabeth Dowling Root, PhD ; Marilla G. Lucero, MD, PhD ; Hanna Nohynek, MD, PhD ; Veronica Tallo, PhD ; Rebecca Stubbs, BA ; Eric A. F. Simões, MB; BS, DCH, MD
  • 1883_Root.pdf (837.0 kB)
  • Cost-Effectiveness of Alternative Strategies for Use of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Canadian Adults
    Derek Weycker, Ph.D. ; Mark Atwood, MS ; Reiko Sato, PhD ; Linda Beausoleil, BA ; Craig Laferriere, PhD ; Shelly a. Mcneil, MD, FRCPC, FIDSA
    Pneumococcal Pneumonia Requiring Hospitalization in US Children in the 13-Valent Pneumococcal Conjugate Vaccine Era
    Liset Olarte, MD ; William J. Barson, MD, FPIDS ; Ryan M Barson, MD ; Jose R. Romero, MD ; John S. Bradley, MD, FPIDS ; Tina Tan, MD, FIDSA ; Laurence B. Givner, MD ; Jill Hoffman, MD ; Philana Ling Lin, MD ; Kristina G. Hulten, PhD ; Edward Mason Jr, PhD ; Sheldon L. Kaplan, MD, FIDSA
    Factors Affecting  Compliance with 13-valent Pneumococcal Conjugate Catch-up Vaccination in Children 
    Deena Sutter, MD ; Scott Barnett, PhD ; Joshua Anchan, MD ; Ashley M. Maranich, M.D.
    Influence of respiratory viruses on the evaluation of 13-valent pneumococcal conjugate vaccine effectiveness in children under 5 years old. A time-series study 2001-2014
    Angela Gentile, MD ; Maria Del Valle Juarez, MD ; Maria Florencia Lucion, MD ; Ana Clara Martinez, MD ; Viviana Romanin, MD ; Norberto Giglio, MD ; Julia Bakir, MD
    Poor immunogenicity of one-dose 13-valent pneumococcal conjugated vaccine in hematopoietic stem cell transplantation recipients
    Hsin-Yun Sun, MD ; Jia-Hau Liu, MD ; Bor-Sheng Ko, MD ; Chi-Cheng Li, MD ; Ming Yao, MD ; Jih-Lu Tang, MD ; Wang-Huei Sheng, PhD
  • HSCT PCV13.pdf (468.4 kB)
  • Vaccination With Pneumococcal Polysaccharide Vaccine Is Associated With Detection Of Specific Pneumococcal Serotypes In Adults Hospitalized For Community-Acquired Pneumonia
    Carlos G. Grijalva, MD, MPH ; Richard Wunderink, MD ; Yuwei Zhu, MD, MS ; Derek J. Williams, MD, MPH ; Robert Balk, MD ; Sherene Fakhran, MD, MPH ; Mark Courtney, MD ; Evan J. Anderson, MD ; Chao Qi, PhD ; Christopher Trabue, MD ; Andrew Pavia, MD, FIDSA, FSHEA, FPIDS ; Matthew R. Moore, MD ; Seema Jain, MD, MPH ; Kathryn Edwards, MD, FIDSA ; Wesley H. Self, MD, MPH
  • IDWeek.pdf (901.3 kB)
  • Incidence of Invasive Pneumococcal Disease (IPD) post Pneumococcal Conjugate Vaccines in Toronto/Peel, Canada, 2001–2015
    Allison Mcgeer, MD, MSc, FRCPC, FSHEA ; Wallis Rudnick, MSc ; Karen Green, MSc ; Agron Plevneshi, BSc ; Sylvia Pong-Porter, MLT
    Economic Analysis of Pneumococcal Vaccination for Elderly Adults in Quebec: Forecasting Invasive Pneumococcal Disease (IPD) Rates of and Serotype Distribution
    Philippe De Wals, MD, PhD ; Zhou Zhou, MD, PhD ; Brigitte Lefebvre, PhD ; Geneviève Deceuninck, MD, MSc
  • IDWEEK Poster no.1894.pdf (1.0 MB)
  • Impact of PCV7 and PCV13 on the Serotype Distribution of Invasive Pneumococcal Disease in Adults in Kansas City
    Fernando Merino, MD ; Erin Atwood, BS ; Rebecca Horvat, PhD ; Douglas Swanson, MD ; Christopher Harrison, M.D., FSHEA, FPIDS ; R. Scott Duncan, Ph.D. ; Maria J Tort, PhD ; Angee Mcdaniel, PharmD
    Association of Streptococcus pneumoniae meningitis after head injury or brain surgery — California, 2013–2014
    Mark Gallivan, MPH ; Erin Murray, MSPH, PhD ; Kathleen Harriman, PhD, MPH, RN

    CME Credits:

    ACPE Credits:

    ACPE Number:

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.